USA – FDA launches new clinical trial center to improve innovation, communication

The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has launched a new center for internal and external experts to discuss new methods for designing and conducting clinical drug trials, dubbed the Center for Clinical Trial Innovation (C3TI).

The center will act as a hub to share lessons learned from its other clinical trial initiatives with the drug development community and is meant to promote clinical trial innovation.

“C3TI will be a central hub within CDER to support the implementation of innovative approaches to clinical trial design and conduct,” said Kevin Bugin, deputy director of operations in the Office of New Drugs (OND) who has been appointed to lead C3TI. “C3TI’s mission is to promote existing and future CDER clinical trial innovation through enhanced communication and collaboration.”…